D
Arbutus Biopharma Corporation ABUS
$4.19 -$0.08-1.87% NASDAQ
Recommendation
Prev Close
$4.27
Volume
36,224
Avg Vol (90D)
983,038
Market Cap
$818.55M
Dividend & Yield
--
52-Week Range
$2.71 - $5.10
P/E (TTM)
--
EPS (TTM)
-$0.29
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Arbutus Biopharma (NASDAQ:ABUS) Shares Cross Above 200-Day Moving Average - What's Next?
10/10/2025 - MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Receives "Sell (D-)" Rating from Weiss Ratings
10/9/2025 - MarketBeat
Arbutus Biopharma (ABUS, $4.29) Stochastic Oscillator left the oversold zone on October 07, 2025
10/8/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS) Showcases Promising Liver Disease Research Data
10/7/2025 - GuruFocus
Arbutus Biopharma to present imdusiran, AB-101 data at The Liver Meeting 2025
10/7/2025 - The Fly
Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting 2025
10/7/2025 - Globe Newswire
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
10/3/2025 - Zacks Investment Research
Arbutus Biopharma (ABUS, $4.41) Stochastic Oscillator left the oversold zone on September 26, 2025
9/27/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.32) Stochastic Oscillator left the oversold zone on September 25, 2025
9/26/2025 - Tickeron - Technical Analysis
Analysts Expect SCHB To Hit $28
9/24/2025 - ETF Channel
Arbutus Biopharma (ABUS, $4.25) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 19, 2025
9/20/2025 - Tickeron - Stocks
Arbutus Biopharma (NASDAQ:ABUS) Trading Down 4.6% - Here's Why
9/14/2025 - MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Trading 6.4% Higher - Still a Buy?
9/13/2025 - MarketBeat
Arbutus Biopharma (ABUS, $4.46) RSI Indicator left the overbought zone on September 12, 2025
9/13/2025 - Tickeron - Stocks
Arbutus Biopharma (NASDAQ:ABUS) Hits New 1-Year High - Still a Buy?
9/12/2025 - MarketBeat
Arbutus Biopharma (ABUS, $4.33) price may drop as it broke higher Bollinger Band on Sep 09, 2025
9/10/2025 - Tickeron - Technical Analysis
Arbutus Biopharma Corporation $ABUS Stock Position Raised by Two Seas Capital LP
9/9/2025 - MarketBeat
Adage Capital Partners GP L.L.C. Sells 75,000 Shares of Arbutus Biopharma Corporation $ABUS
9/9/2025 - MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Trading Up 10.1% - Here's What Happened
9/4/2025 - MarketBeat
ADAR1 Capital Management LLC Grows Position in Arbutus Biopharma Corporation $ABUS
9/4/2025 - MarketBeat
Arbutus Biopharma (ABUS, $3.93) price may drop as it broke higher Bollinger Band on Sep 03, 2025
9/4/2025 - Tickeron - Stocks
The volume for Arbutus Biopharma stock increased for one day, resulting in a record-breaking daily growth of 231% of the 65-Day Volume Moving Average
9/3/2025 - Tickeron - Stocks
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?
9/1/2025 - Zacks Investment Research
Arbutus Biopharma (ABUS, $3.65) price may drop as it broke higher Bollinger Band on Aug 26, 2025
8/27/2025 - Tickeron - Technical Analysis
Arbutus Biopharma (ABUS, $3.65) RSI Indicator left the overbought zone on August 26, 2025
8/27/2025 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
$15.42M
EBITDA (TTM)
-$43.24M
EBIT (TTM)
-$44.25M
Net Income (TTM)
-$54.25M
Balance Sheet
Total Assets (Q)
$103.27M
Total Debt (Q)
$5.00M
Total Liabilities (Q)
$20.29M
Book Value Per Share (Q)
$0.433
Cash Flow
Cash from Operations (TTM)
-$60.19M
Cash from Investing (TTM)
$28.39M
Cash from Financing (TTM)
$6.43M
Net Change in Cash (TTM)
-$25.38M
Filings
Filing Date
Wednesday, August 6, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
0.54
7-Day Total Return
-8.71%
30-Day Total Return
14.17%
60-Day Total Return
33.44%
90-Day Total Return
21.45%
Year to Date Total Return
27.36%
1-Year Total Return
10.55%
2-Year Total Return
116.54%
3-Year Total Return
118.23%
5-Year Total Return
31.35%
52-week Low
Apr 09, 2025 - $2.71
52-week High
Sep 11, 2025 - $5.10
Valuation
Market Cap
$818.55M - Small Cap
Enterprise Value
$725.46M
Price/Sales (TTM)
53.31
Price/Book (Q)
9.86
Dividends and Shares
Shares Outstanding
192.40
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.arbutusbio.com
Phone Number
267 469 0914
Address
701 Veterans Circle
Warminster, PA 18974
Country
United States
Year Founded
2005
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline... more
NASDAQ 10/10/2025 10:03AM Eastern Quotes delayed